SLE clinical manifestations stratified by organ systems of SLEDAI-2K
| Variable | Value | No HZ n=340 | HZ event n=82 | P value | Bonferroni adjusted |
| Central nervous system | Yes (%) | 32 (9.4%) | 9 (11.0%) | 0.67 | 1.00 |
| Vasculitis | Yes (%) | 25 (7.4%) | 8 (9.8%) | 0.47 | 1.00 |
| Musculoskeletal | Yes (%) | 65 (19.1%) | 24 (29.3%) | 0.04 | 0.33 |
| Renal | Yes (%) | 78 (22.9%) | 16 (19.5%) | 0.50 | 1.00 |
| Skin | Yes (%) | 139 (40.9%) | 41 (50.0%) | 0.13 | 0.72 |
| Serosal | Yes (%) | 26 (7.6%) | 7 (8.5%) | 0.79 | 1.00 |
| Immunological | Yes (%) | 229 (67.4%) | 51 (62.2%) | 0.38 | 0.98 |
| Constitutional | Yes (%) | 30 (8.8%) | 8 (9.8%) | 0.79 | 1.00 |
| Haematological | Yes (%) | 36 (10.6%) | 8 (9.8%) | 0.83 | 1.00 |
| SLEDAI-2K | Mean±SD | 7.7±6.8 | 8.5±7.8 | 0.32 | – |
| SLEDAI-2KG | Mean±SD | 5.5±3.0 | 5.9±3.1 | 0.34 | – |
HZ, herpes zoster; SLEDAI-2K, SLE Disease Activity Index 2000; SLEDAI-2KG, SLEDAI-2K Glucocorticoid Index.